Five for Friday: Healthtech devices & diagnostics
People are living longer and healthier lives than ever before thanks to major medical innovations in recent decades. These have spawned the healthtech breakthroughs of tomorrow that were introduced in Helsinki this week.
And so, this Friday, we have the pleasure of presenting five Finnish future creators from the subsector: medical devices & diagnostics.
With great demand comes a great solution. As half a billion people worldwide now have diabetes, Optomed can help detecting and preventing disease outbreaks at an early stage via its cost-effective screening method.
“Our key product is Smartscope PRO, a modular hand-held retinal camera for screening and diagnosis of various eye diseases, such as diabetic retinopathy, glaucoma and AMD,” says company founder and CEO Seppo Kopsala.
Artificial Intelligence is taking enormous steps forward in 2017. The company is a trailblazer in the clinical decision support scene, and while it is focusing on neurological disorders, its method is universal.
“Our solution is a cloud-based tool for the comprehensive analysis of patient data,” CEO Lennart Thurfjell explained earlier this year. “We are not replacing doctors, but rather offer them intelligent tools to support accurate early diagnosis.”
This name changer is a game changer. The company previously known as Brainshake provides blood analysis service that takes 230 biomarkers from a single blood sample.
“We have been working in the science world by co-operating with universities, including the big ones like Oxford and Cambridge,” tells a partner of Nightingale health, Tuomas Poskiparta. “Now we are coming out of the closet and aiming to the clinical market.”
“The disruptive power of our technology relies in extensive scientific background and scalability allowing the blood analysis to be used in routine healthcare,” he told as last autumn.
It’s not only your doctor who cares, but also this company, whose product, Kaiku, means ‘echo’ in Finnish.
“Kaiku has been created to break down the barriers of communication between cancer patients and their doctors,” Henri Virtanen, Netmedi’s head of operations, told us a year ago. “The online platform guides a cancer patient through treatment and recovery.”
“Producing the pills is no longer enough for pharmaceutics,” says Lauri Sippola, CEO and co-founder. “Tumors are becoming more common, but various forms of therapy have made treatments more efficient.”
This nanotech startup manufactures thin film sensor modules, whose main markets are the fast-growing wearable personal fitness and medical devices.
“Thin film sensor modules may collect lot of information,” says CEO Sami Lakka. “It is able to monitor actual blood pressure. In addition, the sensor can measure how the heart is performing, and together with contact lenses eye-pressure can be measured as well. All alarming info will be sent to the mobile.”
Good News from Finland is published by Finnfacts, which is part of Finpro.